next is kendra martello, assistant general counsel pharmaceutical research and manufacturers of america, and our final witness is david gaugh, vice president for regulatory science of the generic pharmaceutical association. welcome, everyone. i think you know the drill, the five minutes. there's the timer. and with that we'll be happy to turn to you, mr. gray, for your five minutes. please make sure your microphone is on. >> thank you. good afternoon, members of the energy commerce subcommittee of manufacturing and trade. i am john gray, president and ceo of the health care distribution management association. i want to thank you all for the opportunity to come here today and talk about this critically important problem of prescription drug abuse and it didversion and most importantly what my members are doing to combat that problem. the pharmaceutical industry's primary mission is to operate the most sufficient and safest supply chain in the world. as part of this mission, our members are committed to addressing the serious national problem of prescription drug abuse and to being a par